Merck reports synthesis, use of new peptidomimetic protein prenyltransferase inhibitors Jan. 30, 2001
MMP-13 inhibitors particularly useful for arthritis, atherosclerosis, as claimed by AstraZeneca Jan. 29, 2001
RSS